[go: up one dir, main page]

UA105940C2 - Drug formulation with theobromine and opiate for treatment of cough - Google Patents

Drug formulation with theobromine and opiate for treatment of cough

Info

Publication number
UA105940C2
UA105940C2 UAA201207163A UAA201207163A UA105940C2 UA 105940 C2 UA105940 C2 UA 105940C2 UA A201207163 A UAA201207163 A UA A201207163A UA A201207163 A UAA201207163 A UA A201207163A UA 105940 C2 UA105940 C2 UA 105940C2
Authority
UA
Ukraine
Prior art keywords
opiate
cough
theobromine
treatment
drug formulation
Prior art date
Application number
UAA201207163A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джон Брю
Робін Марк Банністер
Original Assignee
Байокоупі Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байокоупі Лімітед filed Critical Байокоупі Лімітед
Publication of UA105940C2 publication Critical patent/UA105940C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

An agent comprises theobromine and an opiate, for simultaneous, sequential or separate use in therapy. Preferably, the therapy is of cough.
UAA201207163A 2009-11-13 2010-11-12 Drug formulation with theobromine and opiate for treatment of cough UA105940C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
PCT/GB2010/051896 WO2011058374A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
UA105940C2 true UA105940C2 (en) 2014-07-10

Family

ID=41509327

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201207163A UA105940C2 (en) 2009-11-13 2010-11-12 Drug formulation with theobromine and opiate for treatment of cough

Country Status (19)

Country Link
EP (1) EP2498776A1 (en)
JP (2) JP2013510842A (en)
CN (1) CN102740853B (en)
AU (1) AU2010317668C1 (en)
BR (1) BR112012011224A2 (en)
CA (1) CA2780704C (en)
CO (1) CO6551745A2 (en)
EC (2) ECSP12011893A (en)
GB (1) GB0919893D0 (en)
IL (1) IL219769A0 (en)
MX (1) MX2012005538A (en)
NZ (1) NZ599957A (en)
PE (1) PE20121472A1 (en)
PH (1) PH12012500955A1 (en)
RU (1) RU2587329C2 (en)
SG (1) SG10201407496SA (en)
UA (1) UA105940C2 (en)
WO (1) WO2011058374A1 (en)
ZA (1) ZA201204247B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2523588A (en) * 1987-10-08 1989-05-02 Andor Bilas Mixture of substances for stabilyzing metabolism
BR9407414A (en) * 1993-09-07 1996-11-12 Procter & Gamble Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive
HUP9700654A2 (en) * 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US8080554B2 (en) * 2001-12-12 2011-12-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
EP1603533B1 (en) * 2003-02-28 2009-04-15 YM Biosciences Inc. Opioid delivery system
CN1593451A (en) * 2003-09-12 2005-03-16 杨喜鸿 Externally applied medicine for promoting male erection
US20090069363A1 (en) * 2004-12-14 2009-03-12 Shionogi & Co. Ltd. A Legal Entity Of Japan Therapeutic Agent for Constipation
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (en) * 2006-07-25 2008-01-30 안국약품 주식회사 Cough Treatment Composition

Also Published As

Publication number Publication date
ECSP12011893A (en) 2012-10-30
NZ599957A (en) 2014-05-30
AU2010317668B2 (en) 2015-01-22
CN102740853A (en) 2012-10-17
JP2013510842A (en) 2013-03-28
CN102740853B (en) 2015-04-08
GB0919893D0 (en) 2009-12-30
BR112012011224A2 (en) 2017-03-01
CA2780704C (en) 2018-07-17
SG10201407496SA (en) 2015-02-27
MX2012005538A (en) 2012-09-28
AU2010317668C1 (en) 2016-02-11
AU2010317668A1 (en) 2012-06-07
PH12012500955A1 (en) 2013-01-07
WO2011058374A1 (en) 2011-05-19
ZA201204247B (en) 2013-02-27
JP2016041748A (en) 2016-03-31
CO6551745A2 (en) 2012-10-31
PE20121472A1 (en) 2012-11-30
RU2012124063A (en) 2013-12-20
CA2780704A1 (en) 2011-05-19
IL219769A0 (en) 2012-07-31
RU2587329C2 (en) 2016-06-20
ECSP12011892A (en) 2012-09-28
EP2498776A1 (en) 2012-09-19

Similar Documents

Publication Publication Date Title
MX2011007589A (en) Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody.
IL211952A0 (en) Implantable device for the delivery of risperidone and methods of use thereof
TN2013000508A1 (en) Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
ZA201202384B (en) Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
WO2010151698A3 (en) Steerable medical delivery devices and methods of use
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
HK1153926A1 (en) Purin derivatives for use in the treatment of fab-related diseases fab-
MY204500A (en) Dosing regimen associated with long acting injectable paliperidone esters
PH12012501200A1 (en) Therapeutic combinations of theobromine and an antihistamine
WO2011146699A3 (en) Nanochanneled device and related methods
HK1185808A1 (en) Combination therapy comprising vemurafenib and an interferon for use in the treatment of cancer
MX2009013950A (en) Antitumour combinations containing a vegf inhibiting agent and irinotecan.
PH12013500392A1 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
PH12012501369A1 (en) Drug combination with theobromine and its use in therapy
UA105940C2 (en) Drug formulation with theobromine and opiate for treatment of cough
PH12012501203A1 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
WO2010150098A3 (en) Use of quingolide in the treatment of endometriosis, pain and cancer
WO2014023869A3 (en) Therapeutic use of cd44 inhibitor agents against human acute lymphoblastic leukaemia (all)
UA33210U (en) Method for treating ornitosis
UA57852U (en) Method for treating recurrent forms of allergodermatosis in patients with secondary immunodeficiency
UA52520U (en) Method for treating impaired functional state of intestine in newborns and infants
UA37428U (en) Method for improving in vitro fertilization efficacy
UA34815U (en) Method for correcting cytokine state in patients with acute tonsillitis
UA99163C2 (en) Dosing regimen associated with long acting injectable paliperidone esters
UA60256U (en) Method for pathogenetic prophylaxis and treatment of intraventricular hemorrhages in newborns